It allows the determination of the titre of a functional FVIII inhibitor to contribute to the clinical management of congenital hemophilia A in patients over 2 years of age.

The kit provides imidazole buffered plasma, imidazole buffer, and negative and positive controls that improve the repeatability and repoducibility of the assay method.
This kit must be associated with a measurement of the activity of Factor VIII by chronometric method on citrated human plasma.

Expiration date of 3 years from the date of manufacture with storage at -70 ° C.

- Each kit contains five sets of vials, including positive and negative FVIII inhibitor controls
- Excellent repeatability and reproducibility
- Suitable for multicenter clinical studies
- Excellent linearity
- Convenient frozen format, ready to use in minutes, no reconstitution errors

- 10 vials x pool of normal plasma buffered with imidazole (1.5 mL)
- 10 vials x imidazole buffer containing bovine serum albumin (1.5 mL)
- 5 vials x negative control (0.5 mL)
- 5 vials x positive control (0.5 mL)

CRYOcheck™ Chromogenic Factor VIII
CRYOcheck™ Factor VIII Deficient Plasma
Factor IX Inhibitor Plasma Negative Control
Factor IX Inhibitor Plasma Weak Control
Factor VIII Deficient Plasma Native
Factor VIII Inhibitor Plasma
Factor VIII Inhibitor Plasma HCV neg
Factor VIII Inhibitor Plasma Negative Control
Factor VIII Inhibitor Plasma Weak Control
TECHNOCHROM® FVIII:C